doi: 10.1007/s11154-019-09521-z 90 KabirERRahmanMSRahmanI
Nutritional strategies for correcting low glucose values in patients with postbariatric hypoglycaemia: A randomized controlled three-arm crossover trial
Garbo, S., Maione, R., Tripodi, M
Dapagliflozin Dapagliflozin is described chemically as (2S,3R,4R,5S,6R)-2-(4-Chloro-3-(4-ethoxybenzyl)phenyl)-6-(hydroxymethyl) tetrahydro-2H-pyran-3,4,5-triol
By targeting both receptor pathways, Zepbound may address this cycle more effectively than GLP-1-only medications
The fact that these trends were observed only in the group that consumed PE and PE juice emphasizes the need for further research on a larger sample size